NTU568 ¬õÄTµß®è¬ã¨s¦¨ªG -- ­ì®Æ¥H¤sÃĬ°°ò½èµo»Ã¡B®t²§¤Æ
¥¿¦b¥[¸ü......
Top
X
 
·|­û±b¸¹ :
·|­û±K½X :
§Ñ°O±K½X  ¥[¤J·|­û

­ì®Æ¥H¤sÃĬ°°ò½èµo»Ã¡B®t²§¤Æ    HOME > ¬õÄT¤sÃĤ¶²Ð

 

­ì®Æ¥H¤sÃĬ°°ò½èµo»Ã¡B®t²§¤Æ

 

¡@¡@¤@¯ë¦Ì©Ò§tªº¾ý¯»¬ù¦³ 8 ~ 37% ¬°ª½Ãì¾ý¯»¡A¦Ó¤sÃĤ§ª½Ãì¾ý¯»§t¶q³Ì°ª¥i¹F 35.63%¡A°ª©ó¾ðÁ¦¡B¨¡ÀY¡B¥ÌÃŤΰ¨¹aÁ¦µ¥¡C¤sÃĪºª½Ãì¾ý¯»§t¶q¨¬°÷¨Ñµ¹¬õÄTµß§@¬°ºÒ·½¡A°£¦¹¤§¥~¡A¤sÃħó§t¦³°ª¶qÃþ¦ü©ó¿¯­¹ÅÖºûªº¤£·»©Ê¾ý¯»¡A¤£·|³Q¬õÄTµß©Ò¤À¸Ñ¡A¦³§U©ó±±¨î¿}§¿¯f¯f±¡ (Baghurst et al., 1996; Shukla, 1995)¡A¨Ã¥i­°§C¦å¤¤Á`Áx©T¾J»P¤T»Ä¥Ìªoà­¡A¦³®Ä´î§C¦å¤¤¤Î¨xŦ¤ºªº¯×½è§t¶q(Jenkins et al., 1983)¡A¶i¦Ó§ïµ½¤ß¦åºÞ¯gª¬¡Cµo»Ã«áªº¬õÄT¤sÃĨ㦳­°¦å¯×»P§Ü®ñ¤Æµ¥½Æ¦X©Êªº«O°·¥\®Ä¡A³o¤]±N´£°ª¬õÄT²£«~ªº¸gÀÙ»ù­È»PÀ³¥Î©Ê (Ejechi et al., 1999; Omonigho and Ikenebomeh, 2000; Morse et al., 2000)¡C

 

¡@¡@¥ý«e¬ã¨s«ü¥X¡A­Ü¹«¸gÁý­¹¬õÄT¤sÃĤK¶g«á¡A¥iÅãµÛ­°§C¦å²M¤¤Á`Áx©T¾J»P¤T»Ä¥Ìªoà­ªº§t¶q¡A¨ä­°§C®ÄªG¤ñ°_¶Ç²Î¬õÄT¦Ì§ó¬°ÅãµÛ¡C¦¹¥~¡A¬õÄT¤sÃÄ¥i´£¤É°ª±K«×¯×³J¥ÕÁx©T¾J (high density lipoprotein cholesterol, HDL-C) ªº¿@«×¡A¨Ã¥i¨Ï§C±K«×¯×³J¥ÕÁx©T¾J (low density lipoprotein cholesterol, LDL-C) §t¶q¤U­°¡A®ÄªG¦P¼ËÀu©ó¶Ç²Î¬õÄT¦Ì¡C¥»½g¬ã¨sµ²ªG¥çÅã¥Ü¡AÁý­¹¥¼¸g¬õÄTµo»Ã¤§¤sÃÄ¥i­°§C­Ü¹«¦å¯×§t¶q¡A¦ý­YÁý­¹µ¥¶q¤§¬õÄT¤sÃÄ¡A·|§e²{§ó¨Îªº­°¦å¯×®ÄªG¡C¬õÄT¤sÃÄ»P¥¼µo»Ã¤sÃĤ§³Ì¤j®t²§¡A¦b©ó¬õÄT¤sÃĨ㦳ÅãµÛ­°§C LDL-C ¿@«×¦P®É´£°ª HDL-C ¿@«×¤§ÁͶաA¥B¬õÄT¤sÃħt¦³°ª¶qªº§Üµoª¢ª«½è monascin »P ankaflavin¡A¹ï¹w¨¾°Ê¯ßµ°ª¬µw¤Æ¤]¦³À°§U¡C

 

¡@¡@°Ê¯ß¦åºÞ¾À¤W¤§¯×½è´³¶ô²Ö¿n¶q¡A³Q»{¬°¬O°Ê¯ßµ°ª¬µw¤Æµ{«×ªº¤@¶µ­«­n«ü¼Ð¡A­Y¯à¦³®Ä­°§C¯×½è´³¶ô¡A«h¥i¦³®Ä­°§C°Ê¯ßµ°ª¬µw¤Æ¯gªºµo¥Í¡C¥Ñ°Êª«¹êÅ礧°Ê¯ß¦åºÞ¤Á¤ù¹Ï¥iª¾¡A­Ü¹«³sÄò¤K¶gÁý­¹°ªÁx©T¾J¶¼­¹¡A·|³y¦¨°Ê¯ß¦åºÞ¾À²Ö¿n¯×½è´³¶ô¡A¨ä­±¿n¤ñ²v¥i¹F 22.%¡F¦ý­Ü¹«­Y¦P®ÉÁý­¹¬õÄT¤sÃÄ¡A°Ê¯ß¦åºÞ¾À¤Wªº¯×½è´³¶ô«h¥i¤j¶qªº­°§C¡A¥B¨ä­°§C®ÄªG¥i¹F¬õÄT¦Ì¶¼­¹²Õªº 120 %¡C¦]¦¹¥Ñ¥H¤W¬ã¨s¦¨ªG¥iª¾¡A¬õÄT¤sÃĨ㦳ÅãµÛ­°§C¦å¯×¤§¥\®Ä¡A¨Ã¥i§ïµ½°Ê¯ßµ°ª¬µw¤Æ²{¶H¡C

 

¡@¡@°ªÁx©T¾J¶¼­¹·|³y¦¨Á`§Ü®ñ¤Æ¤O¡B¶W®ñª[¤Æ–¡¬¡©Ê»PIJ–¡¬¡©ÊÅãµÛ¤U­°¡C¬ã¨sÅã¥Ü¡A­Ü¹«¸g¨C¤éÁý­¹¬õÄT¤sÃÄ 9.6 mg¡A¥i´£¤É¦å²G¤Î¨xŦ¤¤ªº§Ü®ñ¤Æ»Ã¯À¦p¶W®ñª[¤Æ–¡¡BIJ–¡¤§¬¡©Ê¡A¹ïÁ`§Ü®ñ¤Æ¤O¤]¥i´£¤É¡A¨ä®ÄªGÀu©ó¬õÄT¦Ì¶¼­¹²Õ»P­°Áx©T¾JÃĪ«²Õ¡C¸g¹L¼Æ¾Ú¤ñ¸û«áµo²{¡A¬õÄT¤sÃĸû¬õÄT¦Ì¯à¦³®Ä´£°ª 67.3% ¤§¶W®ñª[¤Æ–¡¬¡©Ê¡B18.3% ¤§Á`§Ü®ñ¤Æ¤O»P 25.7% ¤§Ä²–¡¬¡©Ê¡C

 

¡@¡@¦b¬õÄT¤sÃĽո`¦å¿}¤è­±¡A¥HÃĪ« (streptozotocin) »¤¾É¦Ñ¹«²£¥Í¿}§¿¯f¯gª¬¡A¶i¦æ 6 ¶g¹êÅç«áÆ[¹î¥iª¾¡AÁý­¹¬õÄT¤sÃĤ§¿}§¿¯f¦Ñ¹«¨ä¦å²G¸²µå¿}¡BÁx©T¾J¡B¤T»Ä¥Ìªoà­¡B´åÂ÷¯×ªÕ»Äµ¥§t¶q¬Ò»·§C©ó±±¨î²Õ¦Ñ¹«¡F¨ä¯ØŦ¤¤ªº§Ü®ñ¤Æ»Ã¯À¬¡©Ê¸û±±¨î²Õ¦Ñ¹«¨}¦n¡F¨äµoª¢«P¶i¦]¤l (IL-1£], IL-6, ITF-£^, TNF-£\) §t¶q§C©ó±±¨î²Õ¦Ñ¹«¡F¥t¥~¡A±q¯ØŦªº²Õ´¤Á¤ù¥iµo²{¡AÁý­¹¬õÄT¤sÃIJդ§¯ØŦ·l¶Ë¤ñ±±¨î²Õ¦Ñ¹«­n¨Óªº§C¡Cºî¦X¥H¤W¹êÅçµ²ªG±oª¾¡A¬õÄT¤sÃĤ£¶È¯à±±¨î¿}§¿¯f¯gª¬¡B´£¤ÉÅ餺§Ü®ñ¤Æ¯à¤O¡B«OÅ@²Õ´§K¨üÃĪ«·l¶Ë¡AÁÙ¨ã§Üµoª¢¤§¥\®Ä¡AÅã¥Ü¬õÄT¤sÃĨ㩵½w¿}§¿¯f±¡©Î¨ä¨Öµo¯gµo®i¤§¼ç¤O¡C

 

¡@¡@°£¤F½Õ¸`¦å¯×¡B¦å¿}¥\¯à¡A¬õÄT¤sÃĤ]¨ã¦³­°¦åÀ£ªº®ÄªG¡C¥ý«e¬ã¨s¨Ï¥Î¦Ûµo©Ê°ª¦åÀ£¤j¹«¬°¼Ò¦¡¦Ñ¹«¡A¥H«D«I¤J¦¡¦åÀ£¾÷´ú¶q¤j¹«ªº§À¯ß·i¡A¤À§OÁý­¹¬õÄT¦Ì»P¬õÄT¤sÃÄ¡Aµû¦ô¬õÄT¦Ì»P¬õÄT¤sÃĦbµu®Ä©Ê (24 hr) »Pªø®Ä©Ê (8 ¶g) ­°¦åÀ£®ÄªG¡Cµ²ªGµL½×¬O¦bµu®Ä©Ê©Î¬Oªø®Ä©ÊÁý­¹¬õÄT¤sÃĮĪG¬Ò¤ñ¬õÄT¦Ì¸û¨Î¡C¦bµu®Ä©Ê¬õÄT¤sÃÄÁý­¹¤@­¿¾¯¶q (150 mg/kg) ¥i­°§C¦¬ÁYÀ£ 13 mmHg »PµÎ±iÀ£ 19 mmHg¡A¥B«ùÄò¦Ü¤K¤p®É«á¤´¦³®ÄªG¡FÁý­¹¤K¶g«á¬õÄT¤sÃÄÅãµÛ­°§C¦¬ÁYÀ£ 27 mmHg »PµÎ±iÀ£ 22 mmHg¡AÅã¥ÜµL½×¬Oµu´Á24¤p®É©Îªø´Á¤K¶gÁý­¹¬õÄT¤sÃħ¡¦³ÅãµÛ­°§C¨ä¦åÀ£¥\®Ä¡C¦b¥Í¤Æ­ÈÀË´ú¤è­±¡A¬õÄT¤sÃĤ£·|³y¦¨¨x¡BµÇ¥NÁ­t¾á¡A¨Ã¥¼ÅãµÛ³y¦¨ AST (aspartate aminotransferase) ¤ÎALT (alanine aminotransferase) ¿@度¤W¤É¡A¥B¤]¥¼³y¦¨¦Ù¦×¡B¤ß«ß¼vÅT¤ÎÅ餺¹q¸Ñ½è¤£¥­¿Å¡C

 

¡@¡@¬õÄT¤sÃħt¦³°ª¶qªº§Üµoª¢ª«½è monascin »P ankaflavin¡A¥H¤Î­°¦åÀ£ª«½è GABA¡C®Ú¾Ú¥H¤W¤åÄm¡A§Q¥Î¬õÄTµßµo»Ã¤sÃÄ¡A±N¥i±o¨ì¸û¬õÄTµo»Ã¦Ì§t¶q§ó°ªªº¥\¯à©Ê¥NÁ²£ª«¡A¦Ó³o¨Ç°ª»ù­Èªº¥\¯à©Ê¥NÁ²£ª«¤]·|§e²{§ó¨Îªº½Õ¸`¦å¯×¡B¦åÀ£¡B¦å¿}¡B¹w¨¾°Ê¯ßµ°ª¬µw¤Æ»P§ïµ½ªü¯÷®üÀq¯gªº®ÄªG¡C¦]¦¹¥i±À½×¥H¬õÄTµo»Ã¹L«á¤§¤sÃÄÀ³¥i´£¤É¬õÄT©Î¤sÃÄ¥»¨­©Ò¦U¦Û¨ã¦³ªºªþ¥[»ù­È¡A¨Ã¨Ï«O°·¥\®Ä¨ã¦³¬Û­¼®ÄªG¡A¦¨¬°·s¤@¥N½Æ¦X©Ê¥\®Äªº¬õÄT«O°·­¹«~¡C

 

°Q½×°Ï ¤Íµ½¦C¦L

¡@¡@¡@Copyright © 2008  All Rights Reserved